RABINOWITZ DANIEL

About RABINOWITZ DANIEL

Daniel Rabinowitz serves as Secretary and Chief Legal Officer at Natera, Inc., a U.S.-listed diagnostics company focused on genetic testing across oncology, women’s health, and organ health. Company disclosures indicate that he has held the Secretary and Chief Legal Officer title since April 2021, after previously serving as Secretary and General Counsel. His career reflects deep specialization in corporate law, capital markets, governance, and regulatory compliance in a highly regulated life sciences environment. Before joining Natera, Rabinowitz was a corporate partner at McDermott, Will & Emery and, earlier, a corporate lawyer at Davis Polk & Wardwell. Natera states that he worked in both the United States and Europe, advising domestic and foreign, public and private companies on capital raisings, mergers and acquisitions, investment management, and compliance with U.S. federal and state securities laws. That background suggests a legal executive with substantial transactional experience and a strong command of public-company governance matters. His academic credentials include a bachelor’s degree and an LLB from the University of the Witwatersrand in South Africa, as well as an LLM from New York University School of Law. Natera also notes that he studied genetics, biochemistry, and molecular biology at Harvard University Extension School, a detail that is particularly relevant in a diagnostics company where scientific, legal, and commercial issues often intersect. In practical terms, Rabinowitz’s role supports Natera’s board and management team on legal strategy, risk oversight, disclosure discipline, and the execution of financing and strategic transactions. In a public company operating in U.S. healthcare and diagnostics, the Chief Legal Officer is often central to maintaining compliance standards, coordinating external counsel, and helping ensure that major corporate actions are implemented with appropriate governance controls. Public sources do not attribute a long list of standalone business transformations or operating roles to him, so the most accurate characterization is that of an experienced in-house legal leader whose value lies in transactional judgment, regulatory rigor, and governance support for a fast-moving public company.